Evidence map›Paper›PMID 41140215›Full record

Observational studyCurrent Alzheimer research2025

Spectral Biomarkers of Functional Brain Network Alteration in Alzheimer's Disease.

Soudeh Behrouzinia, Mehdi Afshar, Alireza Khanteymoori

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Current Alzheimer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Soudeh BehrouziniaDepartment of Computer Engineering, Faculty of Engineering, University of Zanjan, Zanjan, Iran.
Mehdi AfsharDepartment of Mathematics and Statistics, Za.c, Islamic Azad University, Zanjan, Iran.
Alireza KhanteymooriDepartment of Psychology, University of Freiburg, Freiburg, Germany.ORCID 0000-0001-6811-9196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe primary objective of this study was to examine changes in brain network architecture across multiple frequency bands using spectral analysis of both weighted and binarized functional connectivity networks. This cross-sectional observational study, conducted as a secondary analysis of a publicly available EEG dataset, analyzed spectral coherence measurements from 25 patients with Alzheimer's disease (AD) and 25 age- and sex-matched healthy controls (HC). Nevertheless, the modest sample size and cultural homogeneity of the dataset may limit the statistical power and generalizability of the results. A data-driven thresholding approach was employed to generate binary networks, allowing a robust comparison of connectivity disruptions associated with AD.

methodBrain network features derived from the graph Laplacian, including weighted Fiedler value, spectral range, and Middle Eigenvalue, were analyzed across seven frequency layers: delta, theta, alpha1, alpha2, beta1, beta2, and gamma. For binary networks, the Fiedler value was calculated after thresholding. Statistical group comparisons between AD and HC were performed using t-tests (p < 0.05), and each feature was assessed based on the number of frequency bands showing significant differences.

resultsAmong all features, the weighted Fiedler value was the most discriminative, showing significant reductions in AD patients within the alpha2 and beta1 bands. In binary networks, the Fiedler value remained significantly lower in AD within the alpha2 band, confirming topological degradation even without edge weight information. Other spectral features showed similar trends, but did not reach statistical significance in the binary networks. DISCUSSION: The consistent decline in Fiedler value across both weighted and binary networks indicates a global reduction in connectivity characteristic of AD. These spectral markers offer a quantitative and interpretable framework for understanding the progressive disconnection syndrome in AD.

conclusionThis study demonstrates significant alterations in Laplacian spectral features of brain networks between the AD and HC groups across specific frequency bands. These exploratory findings indicate that the spectral features, particularly the Fiedler value, consistently differentiate AD patients from healthy controls across frequency bands, suggesting its potential as a biomarker. However, larger and longitudinal studies are needed to confirm its diagnostic and prognostic utility. The combined use of weighted and binarized connectivity matrices enhances analytical sensitivity and facilitates the application of spectral graph theory for the early detection and monitoring of AD.

Indexed as

Alzheimer DiseaseBrainNerve NetAgedAged, 80 and overBiomarkersCross-Sectional StudiesElectroencephalographyFemaleHumansMaleMiddle AgedNeural PathwaysBiomarkersAlzheimer’s diseaseBrain networkscomplex networkseigenvaluesfunctional connectivitygraph laplacianmultiplex brain network.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.